天津市龙济医院正规吗(天津武清龙济医院门诊做包皮手术好吗) (今日更新中)

At a quick glance through her office, you might think Laura Packard was working on the campaign trail. But this small business owner is fighting to keep her own title: cancer survivor.“A little over three years ago, I walked into a doctor's office with a nagging cough and walked out with a stage four cancer diagnosis. Everything changed for me all at once,” said Packard.She underwent chemotherapy and radiation over a six-month period. “I lost all my hair. Some days, I wouldn't be able to get out of bed, and there was a lot of pain,” she recalled.After multiple surgeries and hospitalizations, she said her bills were really piling up. “I think it was near a million dollars,” said Packard of her medical bills.She says, thankfully, her insurance through the Affordable Care Act saved her in more ways than one.“I've been self-employed off and on for over a decade, and I used to have junk insurance, and if I still had that insurance today, I would be bankrupt or dead,” said Packard.However, she’s worried this level of insurance coverage won’t last with the recent Supreme Court confirmation and once the election results become final.“The day after my first chemotherapy was when Republicans in the House voted to dismantle the Affordable Care Act, which was keeping me alive,” she said.As talks of repealing the ACA gained ground, she moved hundreds of miles away from family to live in Colorado.“Colorado has pretty good state-level protections, but nobody should have to live like this. Nobody should have to be a health care refugee in their own country just to get care, and state-level protections can only go so far. What you need is a federal law to protect everybody.”She, like so many Americans, is wondering how she will pay for her coverage if her costs go up. Packard is fearful her health will suffer if she can’t afford her premiums.“My life is in the balance, but millions of Americans are in the balance, too.”She is worried those with pre-existing conditions won’t be able to get the care they need at a price they can afford.She is also concerned the individual mandate for health insurance will be taken away. With fewer healthy people paying into the healthcare system, the system cannot help cover costs for people who are sick.“My fear is that the rest of the affordable care act will tumble because we won’t be able to sustain it in its totality,” said Michele Lueck, president of Colorado Health Institute.Packard is just one of millions being helped by the subsidies the Affordable Care Act is founded on, and while she knows the Affordable Care Act could be improved, she hopes it will be the building block for even better care, instead of waiting years for a new solution.“I don't even know how many people will die if they succeed in destroying the Affordable Care Act, because people will lose their insurance and people will die,” said Packard.The struggle is something all Americans have endured this year. This cancer survivor is just hoping this election will bring a confirmation that her health is valued.“In a pandemic, it's more clear than ever that we're all in this together and we need candidates and elected officials that work for the greater good,” said Packard. 3224

At a White House news conference on Friday, leaders of Operation Warp Speed said that two coronavirus vaccines could receive emergency use authorization from the FDA in the coming weeks.In addition, Dr. Moncef Slaoui, who is the scientific head of Operation Warp Speed, projected that up to 20 million coronavirus vaccines could be shipped by the end of the year."If approved, they could be used for immunization in the U.S. population in the month of December," Slaoui said. "And we plan to have enough vaccine doses available for use in the U.S. population to immunize about 20 million individuals in the month of December, and another 25 to 30 million per month on an ongoing basis thereon."Given that doses of the two vaccines come in two doses, it could take many months and be well into 2021 before the majority of the American population is vaccinated against the coronavirus.The update came as the virus spreads throughout the country at an alarming and uncontrolled rate. At least 100,000 Americans are confirmed to have contracted the virus every day for the last 10 days, culminating in a record-shattering 153,000 cases on Thursday. Hospitalizations linked to the virus have reached all-time highs since the pandemic began, and deaths linked to the virus are beginning to tick up as well.The update also comes days after Pfizer announced that its vaccine candidate has been 90% effective in Phase 3 trials. The company says it is on track to apply for Emergency Use Status by the end of the month, meaning that some Americans could receive the vaccine before the year's end.New York Gov. Andrew Cuomo, who said his state would independently review vaccine candidates before authorizing distribution to the state, was a frequent target during Friday’s news briefing.“Vaccines will be allocated pro rata by population so we ensure fair and equitable across. We need the states who are part of the planning to accept the vaccine,” saidArmy General Gustave F. Perna, who is overseeing logistics and distribution for Operation Warp Speed. “We are working closely along with the CDC, the jurisdictions and states to ensure vaccine can safely and quickly get to those who need it first.”Trump blasted Cuomo for utilizing an independent review process separate from the FDA. "We won't be delivering it to New York until we have authorization to do so," Trump said. "That pains me to say that. This is a very successful, amazing vaccine that 90% or more. The governor, Gov. Cuomo will have to let us know when he's ready for it. Otherwise, we can't be delivering it to a state that won't be giving it to its people immediately. I know the people of New York very well, I know they want it. The governor will let us know when he's ready."Pfizer said it expects to have 50 million doses of its vaccine ready for global distribution by the end of 2020, and 1 billion doses globally by the end of 2021. That's why other vaccines are also being looked in hopes of getting as many Americans vaccinated as soon as possible. Trump and others on Operation Warp Speed confirmed that health care workers and the elderly would be first to receive doses of the vaccine. Dr. Anthony Fauci, the Trump administration's top infectious disease expert, predicted earlier this week that the vaccine would be widely available in April.Previously, Trump had suggested that a vaccine would have been approved in October and widely available by the start of 2021. Project Warp Speed leaders, however, credited the federal government's response to the virus even if the vaccine has not been distributed as quickly as previously suggested.Friday's remarks were Trump's first on-camera comments since Joe Biden was projected as the winner of the presidential election. Trump had not delivered comments to the press on-camera since Nov. 5, when at a press conference in the White House press room he falsely claimed he would win the presidential election on still-baseless claims of widespread voter fraud.Trump has appeared on camera just once in the last week — a Veteran's Day appearance at Arlington National Cemetery at which he did not speak.Trump's extended media blackout is out of step with the first four years of his administration. Trump has rarely shied away from speaking with reporters, as he often makes himself available for on-camera interviews with the White House press pool on the front lawn and has taken to calling friendly media outlets for phone interviews.However, since last Thursday, Trump has only delivered statements through his Twitter account, where he has continued to spread misinformation about the 2020 election. In the past week, Twitter has taken action on about 50 of Trump's tweets or retweets — be it adding a link to more information, adding a fact check or hiding the tweet from timelines completely. 4827

At Uptown Wines, Beer & Spirits, sales have surged since the COVID-19 crisis started and are expected to rise even more during the holidays.“Last time I’ve seen sales like this, it would be considered New Year’s, Thanksgiving and Halloween night,” said beer specialist Wiley Deerman.Deerman says with more people quarantined at home many started stocking up on alcohol to-go.“We’ve seen a lot of these half-sized bottles, the sales have increased on those,” he said.Now, new research from Vanderbilt University shows not only are more people drinking alcohol and abusing other drugs during the pandemic, but that this increase could create new addicts as well.“You’re seeing an increase in drinking, in drug use in people at home. When the pandemic’s over, this isn’t going to go away," said Erin Calipari, Ph.D., with the Vanderbilt Center for Addiction Research.Calipari’s team conducted the study, which shows addiction triggers during the COVID-19 crisis could make the holiday season even worse for many adults struggling with sobriety.To help fight this problem, Calipari says America needs the same kind of investment in battling addiction as is being put into solving the pandemic.“Addiction kills just as many people as the pandemic has this year and we haven’t done the same thing,” she said. “We’ve kind of, you know, funded it a little bit but we haven’t had this community investment and this kind of global revelation that this is a problem that we should be solving.”Without proper attention, Calipari predicts addiction cases will continue to increase across the country, even after there’s a cure for COVID-19.“This isn’t going to go away when we get the vaccine or solve the pandemic,” she said. “This is going to be a kind of long-term problem that we’re going to have to deal with as a society.”A very costly problem both in money and human lives.That’s why Deerman’s business focuses on more than making a buck, saying the best way to serve his community is to sometimes actually not serve them at all.“There’s times where we have to say, ‘Look, I think you need to cut back, take it easy. we care about you,’” he said.Care about stopping an addiction before it even starts. 2203

As vaccinations get underway in the United Kingdom, United States and other rich countries who could afford to pre-purchase doses of the COVID-19 vaccines, researchers warn that about a quarter of the world’s population will be unable to be vaccinated until 2022.There are 13 vaccine manufacturers working on coronavirus vaccines, and they are capable of producing around 6 billion courses of vaccine by the end of 2021.“Just over half (51%) of these doses will go to high income countries, which represent 14% of the world’s population,” researchers from the Johns Hopkins Bloomberg School of Public Health wrote in their report, published in the British Medical Journal."Of the 13 manufacturers, only six have sold to low and middle-income countries,” they noted.At the time of the report, the U.S. had reserved 800 million doses of the vaccine. Japan and Australia, which account for fewer than 1% of the world’s COVID-19 cases, have reserved and potential options to get 1 billion doses.“Even if all 13 of these vaccine manufacturers were to succeed in reaching their maximum production capacity, at least a fifth of the world’s population would not have access to vaccines until 2022,” researchers noted.Covax, a global effort organized by the World Health Organization, had made initial purchases of 300 million vaccine doses. Covax is working to create equitable access to COVID-19 tests, treatments and vaccines for all countries. President Donald Trump’s administration said they would not participate in the effort."This study provides an overview of how high-income countries have secured future supplies of COVID-19 vaccines, but that access for the rest of the world is uncertain," the researchers concluded. "Governments and manufacturers might provide much-needed assurances for the equitable allocation of COVID-19 vaccines through greater transparency and accountability over these arrangements." 1921

As the coronavirus pandemic continues, doctors are learning more about the damage having Covid-19 can do to the body. Two separate studies published recently indicate the coronavirus can harm other organs in the body, including the heart.One of the studies looked at 100 patients in Germany who recently recovered from Covid-19 and found 60 percent of participants had inflammation in the heart. The study used MRI scans to monitor the inflammation, and was published in JAMA Cardiology.The majority of the patients in this study, 67 of them, recovered from the coronavirus at home with severity ranging from asymptomatic to moderate. It compared the MRIs of coronavirus survivors to scans from healthy volunteers.The data showed there was some sort of heart involvement in those who had coronavirus, whether or not they had preexisting conditions or any heart-related symptoms during recovery.“Our findings reveal that significant cardiac involvement occurs independently of the severity of original presentation and persists beyond the period of acute presentation, with no significant trend toward reduction of imaging or serological findings during the recovery period. Our findings may provide an indication of potentially considerable burden of inflammatory disease in large and growing parts of the population and urgently require confirmation in a larger cohort,” the researchers noted in conclusion.A second study, also published in JAMA Cardiology, found coronavirus could be found in the heart tissue of patients who died.The study looked at data from 39 autopsy cases in Germany in early April. The patients were aged 78 to 89, had tested positive for Covid-19 and there were results of heart tissue analysis in their autopsies.In 16 of the 39 cases, there was a large “virus load” of coronavirus found in the heart tissue, another eight had a coronavirus presence in the tissue.The sample of autopsy cases was small and the "elderly age of the patients might have influenced the results," the researchers wrote. More research is needed whether similar findings would emerge among a younger group of patients."Taken together the studies support that SARS-CoV-2 does not have to cause clinical myocarditis in order to find the virus in large numbers and the inflammatory response in myocardial tissue. In other words, one can have no or mild symptoms of heart involvement in order to actually cause damage," said Dr. Dave Montgomery, who was not involved in the studies, in a statement to CNN.Dr. Clyde Yancy of Northwestern University Feinberg School of Medicine and Dr. Gregg Fonarow of the University of California, Los Angeles, co-authored an editorial that accompanied the two new studies in the journal JAMA Cardiology called ‘Coronavirus Disease 2019 (COVID-19) and the Heart—Is Heart Failure the Next Chapter?”“We see the plot thickening and we are inclined to raise a new and very evident concern that cardiomyopathy and heart failure related to COVID-19 may potentially evolve as the natural history of this infection becomes clearer,” they write. 3076

来源：资阳报